Geller, EJ, Wu, JM, Jannelli, ML, Nguyen, TV, and Visco, AG. "Neonatal outcomes associated with planned vaginal versus planned primary cesarean delivery." J Perinatol 30, no. 4 (April 2010): 258-264.
Anthony Gabriele Visco, MD
Robotic sacrocolpopexy, robotic hysterectomy, outcomes for surgical and non-surgical treatments of urinary incontinence and pelvic organ prolapse, robotic surgery, mesh erosion, Botox therapy for urge incontinence, innovation and entrepreneursihp.
Education and Training
- Resident, Obstetrics & Gynecology, University of Rochester, 1993 - 1997
- M.D., SUNY Upstate Medical University, 1993
Selected Grants and Awards
- Building Interdisciplinary Research Careers in Women's Health
- NICHD Pelvic Floor Disorders Network (PFDN)
- Duke University Medical Center (DUMC) Pelvic Floor Disorders Network (PFDN) Clinical Site
- Duke KURe Program
- Combination Therapy in the Treatment of Urge Urinary Incontinence: A Randomized, Placebo Controlled Trial
- Translational Research in Pelvic Floor Disorders
- Genetic Epidemiology of Pelvic Organ Prolapse
- Molecular and biochemical Study of Collagen in Prolapse
Brubaker, L, Barber, MD, Nygaard, I, Nager, CW, Varner, E, Schaffer, J, Visco, A, Meikle, S, and Spino, C. "Quantification of vaginal support: Are continuous summary scores better than POPQ stage?." American Journal of Obstetrics and Gynecology 203, no. 5 (2010): 512.e1-512.e6.
Visco, AG, Brubaker, L, Nygaard, I, Richter, HE, Cundiff, G, Fine, P, Zyczynski, H, Brown, MB, and Weber, AM. "The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: The colpopexy and urinary reduction efforts (CARE) randomized surgical trial." Journal of Urology 184, no. 4 (2010): 1421--.
Siddiqui, NY, Amundsen, CL, Visco, AG, Myers, ER, and Wu, JM. "Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence." J Urol 182, no. 6 (December 2009): 2799-2804.
Visco, AG, Meyer, LC, Xi, S, and Brown, CG. "One disease, two lives." Clin J Oncol Nurs 13, no. 4 (August 2009): 426-432.
Advincula, AP, and Visco, AG. "Robotic Gynecologic Surgery Reply." OBSTETRICS AND GYNECOLOGY 114, no. 1 (July 2009): 168-169.
Wu, JM, Siddiqui, NY, Amundsen, CL, Myers, ER, Havrilesky, LJ, and Visco, AG. "Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence." J Urol 181, no. 5 (May 2009): 2181-2186.
Wei, J, Nygaard, I, Richter, H, Brown, M, Barber, M, Xiao Xu, , Kenton, K, Nager, C, Schaffer, J, Visco, A, Weber, A, and Pelvic Floor Disorders Network, . "Outcomes following vaginal prolapse repair and mid urethral sling (OPUS) trial--design and methods." Clinical Trials (London, England) 6, no. 2 (April 2009): 162-171.
Advincula, AP, and Visco, AG. "In Reply." Obstetrics and Gynecology 114, no. 1 (2009): 168-169.
Cundiff, GW, Varner, E, Visco, AG, Zyczynski, HM, Nager, CW, Norton, PA, Schaffer, J, Brown, MB, Brubaker, L, and Pelvic Floor Disorders Network, . "Risk factors for mesh/suture erosion following sacral colpopexy." American Journal of Obstetrics and Gynecology 199, no. 6 (December 2008): 688.e1-688.e5.